Latest News

Under the new arrangement, Remgro now owns 100% of Mediclinic’s Southern African operations through Mediclinic International, while IHL has taken full ownership of the Swiss-based Hirslanden Group.

The new status gives MKRH its own Board of Directors, an approved organizational structure, and direct funding from the National Exchequer.

Under the partnership, the two organizations will work together to enhance HMC’s Clinical Trials Unit (CTU), strengthen research expertise, and develop initiatives that support the continued growth of Qatar’s healthcare sector.

Verzenios is a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor developed by Lilly for the treatment of several forms of breast cancer.

The newly formed organization brings together four established healthcare brands including Aster DM, CARE Hospitals, Evercare and KIMSHEALTH, under a single platform focused on expanding access to advanced and affordable medical care across the country.

Researchers found that postmenopausal women taking hormone therapy while receiving tirzepatide lost approximately 35% more weight than women treated with tirzepatide alone.

The Jasper, Indiana-based electronics and medical contract manufacturer will add Helvoet’s facilities in Tilburg, the Netherlands, and in Pune, India, to its global manufacturing network.

For patients, the recognition reflects a healthcare environment where nurses receive strong institutional support to deliver safe, compassionate, and patient-centred care.

Under the agreement, QuantumCell will obtain global rights to AlzeCure’s NeuroRestore platform, including its lead drug candidate, ACD856.

Researchers can use the platform to design CRISPR screening experiments, analyse single-cell RNA sequencing data and generate three-dimensional protein structures, chemistry drawings and genome browser tracks.